Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sochi C. Osigwe"'
Autor:
Akachukwu Ibezim, Mbanefo S. Madukaife, Sochi C. Osigwe, Nadja Engel, Ramanathan Karuppasamy, Fidele Ntie-Kang
Publikováno v:
BMC Chemistry, Vol 16, Iss 1, Pp 1-9 (2022)
Abstract Type III beta phosphatidylinositol 4-kinase (PI4KIIIβ) is the only clinically validated drug target in Plasmodium kinases and therefore a critical target in developing novel drugs for malaria. Current PI4KIIIβ inhibitors have solubility an
Externí odkaz:
https://doaj.org/article/6a6ea292690840adaf99867b801cc5f7
Autor:
Akachukwu Ibezim, Mbanefo S. Madukaife, Sochi C. Osigwe, Nadja Engel, Ramanathan Karuppasamy, Fidele Ntie-Kang
Publikováno v:
BMC chemistry. 16(1)
Type III beta phosphatidylinositol 4-kinase (PI4KIIIβ) is the only clinically validated drug target in Plasmodium kinases and therefore a critical target in developing novel drugs for malaria. Current PI4KIIIβ inhibitors have solubility and off-tar
Autor:
Sochi C Osigwe, Mbanefo S. Madukaife, Ramanathan Karuppasamy, Nadja Engel, Fidele Ntie-Kang, Akachukwu Ibezim
Plasmodium species that cause malaria, a disease responsible for about half a million deaths per annum despite concerted efforts to combat it. The causative agent depends on type III beta phosphatidylinositol 4-kinase (PPI4K) during the development o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a1b5338c9f9436cc4525253e57abd26
https://doi.org/10.20944/preprints202111.0108.v1
https://doi.org/10.20944/preprints202111.0108.v1